Insulin Access and Affordability Working Group: Conclusions and Recommendations-Reference-Cited by-同舟云学术

Insulin Access and Affordability Working Group: Conclusions and Recommendations

Published:2018-05-11 Issue:6 Volume:41 Page:1299-1311
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Cefalu William T.¹,Dawes Daniel E.²,Gavlak Gina³,Goldman Dana⁴,Herman William H.⁵,Van Nuys Karen⁴^ORCID,Powers Alvin C.⁶,Taylor Simeon I.⁷^ORCID,Yatvin Alan L.⁸,

Affiliation:

1. American Diabetes Association, Arlington, VA

2. Morehouse School of Medicine, Atlanta, GA

3. North Coast Health, Lakewood, OH

4. USC Schaeffer Center for Health Policy & Economics, Los Angeles, CA

5. University of Michigan, Ann Arbor, MI

6. Vanderbilt University Medical Center, Nashville, TN

7. University of Maryland School of Medicine, Baltimore, MD

8. Popper & Yatvin, Philadelphia, PA

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/41/6/1299/553611/dci180019.pdf

Reference50 articles.

1. Economic costs of diabetes in the U.S. in 2017;American Diabetes Association;Diabetes Care,2018

2. Expenditures and prices of antihyperglycemic medications in the United States: 2002-2013;Hua;JAMA,2016

3. American Diabetes Association . Insulin stories [Internet]. Available from https://makeinsulinaffordable.org/insulin-stories/. Accessed 1 March 2018

4. Picchi A . Soaring insulin prices have diabetics feeling the pain [article online]. CBS News MoneyWatch, 25 August 2016. Available from https://www.cbsnews.com/news/soaring-insulin-prices-have-diabetics-feeling-the-pain/. Accessed 1 March 2018

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity, Efficacy, and Safety of Biosimilar Insulin Glargine (Gan & Lee Glargine) Compared With Originator Insulin Glargine (Lantus) in Patients With Type 1 Diabetes After 26 Weeks Treatment;Endocrine Practice;2024-09

2. Health Outcome Changes in Individuals With Type 1 Diabetes After a State-Level Insulin Copayment Cap;JAMA Network Open;2024-08-14

3. State Mandates To Cap Out-Of-Pocket Insulin Costs Are No Longer Necessary;Health Affairs;2024-08-01

4. Colorado Insulin Copay Cap: Lower Out-Of-Pocket Payments, Increased Prescription Volume And Days’ Supply;Health Affairs;2024-08-01

5. Household food insecurity and associations with hemoglobin A1c and acute diabetes-related complications in youth and young adults with type 1 diabetes: The SEARCH for Diabetes in Youth study;Diabetes Research and Clinical Practice;2024-06